Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetes.

समान संसाधन

• Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).
  द्वारा: Davis, T, और अन्य
  प्रकाशित: (2005)
• Glucose control in UKPDS type 2 diabetic patients with and without autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase.
  द्वारा: Mehta, Z, और अन्य
  प्रकाशित: (1999)
• Autoantibodies to islet amyloid polypeptide in diabetes.
  द्वारा: Clark, A, और अन्य
  प्रकाशित: (1991)
• Prevalence of islet autoantibodies in type 1 diabetes
  द्वारा: Devi Dayal, और अन्य
  प्रकाशित: (2017-01-01)
• Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus
  द्वारा: Young Hwa Kong, और अन्य
  प्रकाशित: (2013-06-01)